Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis

Immunology Letters

Volumn 100, Issue 1, 2005, Pages 7-13

  Moretta, Lorenzo ^a,c   Bottino, Cristina ^a   Pende, Daniela ^b   Vitale, Massimo ^b   Mingari, Maria Cristina ^b,c   Moretta, Alessandro ^c  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Activating NK receptors; Cellular ligands; Inhibitory NK receptors; Innate immunity; NK cells

Indexed keywords

HLA ANTIGEN CLASS 1; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW; CELL ACTIVATION; CELL CULTURE; CYTOLYSIS; HUMAN; LEUKEMIA; LYMPHOID CELL; LYMPHOMA; MELANOMA; NATURAL KILLER CELL; NEUROBLASTOMA; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 24344505476     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2005.07.004     Document Type: Review

References (63)

1. G. Trinchieri Biology of natural killer cells Adv Immunol 47 1989 187 276
2. A. Moretta The dialogue between human natural killer cells and dendritic cells Curr Opin Immunol 17 2005 306 311
3. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189 220
4. A. Moretta, C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 19 2001 197 223
5. C. Bottino, R. Castriconi, L. Moretta, and A. Moretta Cellular ligands of activating NK receptors Trends Immunol 26 2005 221 226
6. L.L. Lanier NK cell recognition Annu Rev Immunol 23 2005 225 274
7. P.M.H.C. Parham Class I molecules and KIRs in human history, health and survival Nat Rev Immunol 5 2005 201 214
8. L. Moretta, C. Bottino, D. Pende, M. Vitale, M.C. Mingari, and A. Moretta Different checkpoints in human NK-cell activation Trends Immunol 25 2004 670 676
9. A. Moretta, G. Tambussi, C. Bottino, G. Tripodi, A. Merli, E. Ciccone, G. Pantaleo, and L. Moretta A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function J Exp Med 171 1990 695 714
10. A. Moretta, C. Bottino, D. Pende, G. Tripodi, G. Tambussi, O. Viale, A. Orengo, M. Barbaresi, A. Merli, E. Ciccone, and L. Moretta Identification of four subsets of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignement of NK clones and ability to mediate specific alloantigen recognition J Exp Med 172 1990 1589 1598
11. A. Moretta, M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta p58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities J Exp Med 178 1993 597 604
12. W.M. Yokoyama, and W.E. Seaman The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex Annu Rev Immunol 11 1993 613 635
13. A. Moretta, C. Bottino, M. Vitale, D. Pende, R. Biassoni, M.C. Mingari, and L. Moretta Receptors for HLA-class I molecules in human natural killer cells Annu Rev Immunol 14 1996 619 648
14. H.G. Ljunggren, and K. Kärre In search of the "missing self". MHC molecules and NK cell recognition Immunol Today 11 1990 237 244
15. F. Garrido, F. Ruiz-Cabello, T. Cabrera, J.J. Pérez-Villar, M. Lopez-Botet, M. Duggan-Keen, and P.L. Stern Implications for immunosurveillance of altered HLA-class I phenotypes in human tumours Immunol Today 18 1997 89 95
16. I. Algarra, A. Garcia-Lora, T. Cabrera, F. Ruiz-Cabello, and F. Garrido The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape Cancer Immunol Immunother 53 2004 904 910
17. A. Alcami, and U.H. Koszinowski Viral mechanisms of immune evasion Immunol Today 21 2000 447 455
18. Rajagopalan S, Long EO. Viral evasion of NK-cell activation. Trends Immunol 2005;26:403-5.
19. M. Lopez-Botet, A. Angulo, and M. Guma Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection Tissue Antigens 63 2004 195 203
20. M.B. Lodoen, and L.L. Lanier Viral modulation of NK cell immunity Nat Rev Microbiol 3 2005 59 69
21. M.S. Malnati, M. Peruzzi, K.C. Parker, W.E. Biddison, E. Ciccone, A. Moretta, and E.O. Long Peptide specificity in the recognition of MHC class I by natural killer cell clones Science 267 1995 1016 1018
22. D. Pende, L. Accame, L. Pareti, A. Mazzocchi, A. Moretta, G. Parmiani, and L. Moretta The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles Eur J Immunol 28 1998 2384 2394
23. E.O. Long Regulation of immune responses through inhibitory receptors Annu Rev Immunol 17 1999 875 904
24. J. Trowsdale Genetic and functional relationships between MHC and NK receptor genes Immunity 15 2001 363 374
25. C. Vilches, and P. Parham KIR: diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 2002 217 251
26. L. Moretta, and A. Moretta Killer immunoglobulin-like receptors Curr Opin Immunol 16 2004 626 633
27. H.G. Shilling, N. Young, L.A. Guethlein, N.W. Cheng, C.M. Gardiner, D. Tyan, and P. Parham Genetic control of human NK cell repertoire J Immunol 169 2002 239 247
28. A. Zingoni, T. Sornasse, B.G. Cocks, Y. Tanaka, A. Santoni, and L.L. Lanier NK cell regulation of T cell-mediated responses Mol Immunol 42 2005 451 454
29. S. Sivori, M. Falco, E. Marcenaro, S. Parolini, R. Biasson, C. Bottino, L. Moretta, and A. Moretta Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation Proc Natl Acad Sci USA 99 2002 4526 4531
30. M.H. Brown, K. Boles, P.A. van der Merwe, V. Kumar, P.A. Mathew, and A.N. Barclay 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 J Exp Med 188 1998 2083 2090
31. C. Bottino, M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L.D. Notarangelo, L. Moretta, and A. Moretta NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of NK cells to kill EBV-infected B cells in X-linked lymphoproliferative disease J Exp Med 194 2001 235 246
32. S. Parolini, C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. Ochs, H. Wolf, J.Y. Bonnefoy, R. Biassoni, L. Moretta, L.D. Notarangelo, and A. Moretta X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of NK cell to kill EBV-infected cells J Exp Med 192 2000 337 346
33. A. Velardi, L. Ruggeri, A. Moretta, and L. Moretta NK cells: a lesson from mismatched hematopoietic transplantation Trends Immunol 23 2002 438 444
34. D. Pende, G.M. Spaggiari, S. Marcenaro, S. Martini, P. Rivera, A. Capobianco, M. Falco, E. Lanino, I. Pierri, R. Zambello, A. Bacigalupo, M.C. Mingari, A. Moretta, and L. Moretta Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) Blood 105 2005 2066 2073
35. L. Ruggeri, M. Capanni, M. Casucci, I. Volpi, A. Tosti, K. Perruccio, E. Urbani, R.S. Negrin, M.F. Martelli, and A. Velardi Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 94 1999 333 339
36. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M.F. Martelli, and A. Velardi Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
37. A. Moretta, R. Biassoni, C. Bottino, M.C. Mingari, and L. Moretta Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis Immunol Today 21 2000 228 234
38. C. Bottino, L. Moretta, D. Pende, M. Vitale, and A. Moretta Learning how to discriminate between friends and enemies, a lesson from natural killer cells Mol Immunol 41 2004 569 575
39. S. Sivori, M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta p46, a novel natural killer cell-specific surface molecule which mediates cell activation J Exp Med 186 1997 1129 1136
40. A. Pessino, S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, and A. Moretta Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity J Exp Med 188 1998 953 960
41. D. Pende, S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells J Exp Med 190 1999 1505 1516
42. M. Vitale, C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, R. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis J Exp Med 187 1998 2065 2072
43. C. Cantoni, C. Bottino, M. Vitale, A. Pessino, R. Augugliaro, A. Malaspina, S. Parolini, L. Moretta, A. Moretta, and R. Biassoni NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily J Exp Med 189 1999 787 796
44. S. Sivori, D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells Eur J Immunol 29 1999, May 1656 1666
45. J. Wu, Y. Song, A.B. Bakker, S. Bauer, T. Spies, L.L. Lanier, and J.H. Phillips An activating immunoreceptor complex formed by NKG2D and DAP10 Science 285 1999 730 732
46. S. Bauer, V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 1999 727 729
47. V. Groh, R. Rhinehart, H. Secrist, S. Bauer, K.H. Grabstein, and T. Spies Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB Proc Natl Acad Sci USA 96 1999 6879 6884
48. D. Cosman, J. Mullberg, C.L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N.J. Chalupny ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor Immunity 14 2001 123 133
49. E. Vivier, E. Tomasello, and P. Paul Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr Opin Immunol 14 2002 306 311
50. D.H. Raulet Roles of the NKG2D immunoreceptor and its ligands Nat Rev Immunol 3 2003 781 790
51. A. Cerwenka, and L.L. Lanier NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer Tissue Antigens 61 2003 335 343
52. A. Shibuya, D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G.R. Sutherland, L.L. Lanier, and J.H. Phillips DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes Immunity 4 1996 573 581
53. M. Vitale, M. Falco, R. Castriconi, S. Parolini, R. Zambello, G. Semenzato, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta Identification of NKp80, a novel triggering molecule expressed by human NK cells Eur J Immunol 31 2001 233 242
54. E. Marcenaro, R. Augugliaro, M. Falco, R. Castriconi, S. Parolini, S. Sivori, E. Romeo, R. Millo, L. Moretta, C. Bottino, and A. Moretta CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity Eur J Immunol 33 2003 3367 3376
55. R.T. Costello, S. Sivori, E. Marcenaro, M. Lafage-Pochitaloff, M.J. Mozziconacci, D. Reviron, J.A. Gastaut, D. Pende, D. Olive, and A. Moretta Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia Blood 99 2002 3661 3667
56. A. De Maria, M. Fogli, P. Costa, G. Murdaca, F. Puppo, D. Mavilio, A. Moretta, and L. Moretta The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44) Eur J Immunol 33 2003 2410 2418
57. C. Vitale, L. Chiossone, C. Cantoni, G. Morreale, F. Cottalasso, S. Moretti, A. Pistorio, R. Haupt, E. Lanino, G. Dini, L. Moretta, and M.C. Mingari The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity Eur J Immunol 34 2004 3028 3038
58. R. Castriconi, C. Cantoni, M. Della Chiesa, M. Vitale, E. Marcenaro, R. Conte, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells Proc Natl Acad Sci USA 100 2003 4120 4125
59. D. Pende, P. Rivera, S. Marcenaro, C.C. Chang, R. Biassoni, R. Conte, M. Kubin, D. Cosman, S. Ferrone, L. Moretta, and A. Moretta Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity Cancer Res 62 2002 6178 6186
60. C. Bottino, R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, M. Vitale, L. Moretta, M. Lopez, and A. Moretta Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule J Exp Med 198 2003 557 567
61. R. Castriconi, A. Dondero, M.V. Corrias, E. Lanino, D. Pende, L. Moretta, C. Bottino, and A. Moretta Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction Cancer Res 64 2004 9180 9184
62. R. Castriconi, A. Dondero, R. Augugliaro, C. Cantoni, B. Carnemolla, A.R. Sementa, F. Negri, R. Conte, M.V. Corrias, L. Moretta, A. Moretta, and C. Bottino Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc Natl Acad Sci USA 101 2004 12640 12645
63. A. Moretta, and C. Bottino Commentary, Regulated equilibrium between opposite signals: a general paradigm for T cell function? Eur J Immunol 34 2004 2084 2088